Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial
Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record is displayed, including its study design, eligibility criteria, losartan treatment arms, outcome measures, and participant-data sharing plan.SummaryDifference62%

- Check11 days agoChange DetectedThe site footer revision identifier changed from v3.7.2 to v3.8.0; the page otherwise remains a 403 Forbidden error page.SummaryDifference0.2%

- Check18 days agoChange DetectedAn NIH site-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedNo textual changes were reported for this page. The provided data indicates no updates to the content.SummaryDifference0.2%

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.